Cargando…
Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881721/ https://www.ncbi.nlm.nih.gov/pubmed/33614299 http://dx.doi.org/10.7717/peerj.10918 |
_version_ | 1783650937165840384 |
---|---|
author | Ziaunys, Mantas Sakalauskas, Andrius Mikalauskaite, Kamile Smirnovas, Vytautas |
author_facet | Ziaunys, Mantas Sakalauskas, Andrius Mikalauskaite, Kamile Smirnovas, Vytautas |
author_sort | Ziaunys, Mantas |
collection | PubMed |
description | The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available. When the aggregation of insulin, a model amyloidogenic protein, is tracked using thioflavin-T (ThT), an amyloid specific dye, there is an anomalous occurrence of double-sigmoidal aggregation kinetics. Such an event is likely related to the formation of ThT-positive intermediates, which may affect the outcome of both aggregation kinetic data, as well as final fibril structure. In this work we explore insulin fibrillization under conditions, where both normal and double-sigmoidal kinetics are observed and show that, despite their dye-binding properties and random occurrence, the ThT-positive intermediates do not significantly alter the overall aggregation process. |
format | Online Article Text |
id | pubmed-7881721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78817212021-02-18 Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates Ziaunys, Mantas Sakalauskas, Andrius Mikalauskaite, Kamile Smirnovas, Vytautas PeerJ Biochemistry The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available. When the aggregation of insulin, a model amyloidogenic protein, is tracked using thioflavin-T (ThT), an amyloid specific dye, there is an anomalous occurrence of double-sigmoidal aggregation kinetics. Such an event is likely related to the formation of ThT-positive intermediates, which may affect the outcome of both aggregation kinetic data, as well as final fibril structure. In this work we explore insulin fibrillization under conditions, where both normal and double-sigmoidal kinetics are observed and show that, despite their dye-binding properties and random occurrence, the ThT-positive intermediates do not significantly alter the overall aggregation process. PeerJ Inc. 2021-02-10 /pmc/articles/PMC7881721/ /pubmed/33614299 http://dx.doi.org/10.7717/peerj.10918 Text en ©2021 Ziaunys et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Biochemistry Ziaunys, Mantas Sakalauskas, Andrius Mikalauskaite, Kamile Smirnovas, Vytautas Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title | Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title_full | Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title_fullStr | Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title_full_unstemmed | Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title_short | Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates |
title_sort | exploring the occurrence of thioflavin-t-positive insulin amyloid aggregation intermediates |
topic | Biochemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881721/ https://www.ncbi.nlm.nih.gov/pubmed/33614299 http://dx.doi.org/10.7717/peerj.10918 |
work_keys_str_mv | AT ziaunysmantas exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates AT sakalauskasandrius exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates AT mikalauskaitekamile exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates AT smirnovasvytautas exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates |